Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.
2.

Cell permeable iron chelators as potential cancer chemotherapeutic agents.

Pahl PM, Horwitz LD.

Cancer Invest. 2005;23(8):683-91. Review.

PMID:
16377587
3.

Paradoxical effects of iron chelation on growth of vascular endothelial cells.

Hodges YK, Reese SM, Pahl PM, Horwitz LD.

J Cardiovasc Pharmacol. 2005 Jun;45(6):539-44.

PMID:
15897780
4.

Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cells.

Pahl PM, Horwitz MA, Horwitz KB, Horwitz LD.

Breast Cancer Res Treat. 2001 Sep;69(1):69-79.

PMID:
11759830
5.

Induction of peroxiredoxin gene expression by oxygen in lungs of newborn primates.

Das KC, Pahl PM, Guo XL, White CW.

Am J Respir Cell Mol Biol. 2001 Aug;25(2):226-32.

PMID:
11509333
6.

An exochelin of Mycobacterium tuberculosis reversibly arrests growth of human vascular smooth muscle cells in vitro.

Pahl PM, Yan XD, Hodges YK, Rosenthal EA, Horwitz MA, Horwitz LD.

J Biol Chem. 2000 Jun 9;275(23):17821-6.

7.

ZNF207, a ubiquitously expressed zinc finger gene on chromosome 6p21.3.

Pahl PM, Hodges YK, Meltesen L, Perryman MB, Horwitz KB, Horwitz LD.

Genomics. 1998 Nov 1;53(3):410-2. No abstract available.

PMID:
9799612
8.

mcm5/cdc46-bob1 bypasses the requirement for the S phase activator Cdc7p.

Hardy CF, Dryga O, Seematter S, Pahl PM, Sclafani RA.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3151-5.

9.

Cell cycle regulation of the yeast Cdc7 protein kinase by association with the Dbf4 protein.

Jackson AL, Pahl PM, Harrison K, Rosamond J, Sclafani RA.

Mol Cell Biol. 1993 May;13(5):2899-908.

Supplemental Content

Support Center